Prevention of coronary heart diseaseBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7436.405-a (Published 12 February 2004) Cite this as: BMJ 2004;328:405
Incremental cost effectiveness raises issues
- William C D'Avanzo, retired (email@example.com)
- 21B Kenneth Stuart Place, Mohegan Lake, NY 10547
EDITOR—Marshall seemed not to include the cost to the health system of treatment after a myocardial infarction occurs.1 You could go further and estimate the cost to society of prematurely losing productive members.
Say, for example, one myocardial infarction was prevented with treatment A and two with treatment B in a group of 100. If A costs $1 a year and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial